Feb 24, 2022
|
Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) at the University of North Carolina-Chapel Hill, Announces Late-Breaking Oral Presentation at International Conference on Antiviral Research
|
Feb 22, 2022
|
Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Update on March 1, 2022
|
Jan 20, 2022
|
Chimerix to Present at B. Riley Virtual Oncology Conference
|
Jan 18, 2022
|
Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research
|
Jan 03, 2022
|
Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
|